This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kamat, S. G. Articles by Schafer, A. I. Search for Related Content PubMed PubMed Citation Articles by Kamat, S. G. Articles by Schafer, A. I.

(Circulation. 1995;92:1399-1407.)
© 1995 American Heart Association, Inc.

Articles

Fibrinolysis Inhibits Shear Stress–Induced Platelet Aggregation

Suraj G. Kamat, MD; Alan D. Michelson, MD; Stephen E. Benoit, BS; Joel L. Moake, MD; Damodara Rajasekhar, MD; J. David Hellums, PhD; Michael H. Kroll, MD; Andrew I. Schafer, MD

From the Houston VA Medical Center (S.G.K., M.H.K., A.I.S.) and Rice University (J.L.M., J.D.H.), Houston, Tex; and the University of Massachusetts Medical School (A.D.M., S.E.B.) and the Medical Center of Central Massachusetts (D.R.), Worcester, Mass.

Correspondence to Andrew I. Schafer, Chief, Medical Service, Houston Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030.

Background Shear stress–induced platelet aggregation may initiate arterial thrombosis at sites of pathological blood flow. Shear stress–induced platelet aggregation is mediated by von Willebrand factor (vWf) binding to platelet membrane glycoprotein (GP) Ib and GP IIb/IIIa. Tissue-type plasminogen activator (TPA) induces thrombolysis in coronary arteries through the local generation of plasmin. Plasmin also proteolyses GP Ib and plasma vWf.

Methods and Results Because these effects could mitigate shear stress–induced platelet aggregation, we investigated the effect of fibrinolytic agents on platelet aggregation in response to a pathological shear stress of 120 dynes/cm² generated by a cone-and-platen rotational viscometer. Plasmin inhibited shear stress–induced aggregation of washed platelets, and this was associated with a decrease in GP Ib. TPA, at concentrations 2000 IU/mL, significantly inhibited shear stress–induced platelet aggregation of platelet-rich plasma without a decrease in platelet GP Ib. In plasma-platelet mixing experiments, we determined that the TPA effect was localized to plasma. Purified vWf multimer degradation by TPA (in the presence of exogenous plasminogen) was associated with the loss of the capacity of vWf to support shear stress–induced platelet aggregation.

Conclusions These results demonstrate that TPA inhibits platelet aggregation in response to pathological shear stress by altering the multimeric composition of vWf. This effect of TPA on shear stress–induced platelet aggregation may contribute, along with fibrinolysis, to the therapeutic effect of TPA in restoring blood flow during acute coronary artery thrombosis.

Key Words: stress, shear • enzymes • plasminogen activators • platelets

This article has been cited by other articles:

				S. D. Berkowitz, C. B. Granger, K. S. Pieper, K. L. Lee, J. M. Gore, M. Simoons, P. W. Armstrong, E. J. Topol, and R. M. Califf Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction Circulation, June 3, 1997; 95(11): 2508 - 2516. [Abstract] [Full Text]

				H. S. Friedman, W. J. Koroshetz, The Massachusetts General Hospital Stroke Service, N. Qureshi, J. R. Marler, The NINDS-PA Stroke Study Group, and G. J. del Zoppo Tissue Plasminogen Activator for Acute Ischemic Stroke N. Engl. J. Med., May 23, 1996; 334(21): 1405 - 1406. [Full Text]